Tae-im Kim

Seoul, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 31 publications

A Randomized Multicenter Study Comparing Low-Viscosity with Comparator 0.3% Hyaluronic Acid for the Treatment of Dry Eye Disease.

A Randomized Multicenter Study Comparing Low-Viscosity with Comparator 0.3% Hyaluronic Acid for the Treatment of Dry Eye Disease.

Journal: Ophthalmology and therapy

Published: January 25, 2026

"Stepwise Extension Treatment Protocol" versus "Pro Re Nata Regimen" of Intense Pulsed Light for Meibomian Gland Dysfunction.

"Stepwise Extension Treatment Protocol" versus "Pro Re Nata Regimen" of Intense Pulsed Light for Meibomian Gland Dysfunction.

Journal: Ophthalmology

Published: July 11, 2025

Clinical efficacy of induced epiphora by punctal plugging on refractory dry eye disease with ocular surface Damage: Randomized sham-controlled trial.

Clinical efficacy of induced epiphora by punctal plugging on refractory dry eye disease with ocular surface Damage: Randomized sham-controlled trial.

Journal: Contact lens & anterior eye : the journal of the British Contact Lens Association

Published: June 24, 2025

Aqueous-Deficient Dry Eye Increases Lipid Layer Thickness Measured by Dynamic Tear Interferometry.

Aqueous-Deficient Dry Eye Increases Lipid Layer Thickness Measured by Dynamic Tear Interferometry.

Journal: Cornea

Published: March 19, 2024

New Korean Guidelines for the Diagnosis and Management of Dry Eye Disease.

New Korean Guidelines for the Diagnosis and Management of Dry Eye Disease.

Journal: Korean journal of ophthalmology : KJO

Published: August 01, 2023

Corticosteroid-Antibiotic Interactions in Bacteria that Cause Corneal Infection.

Corticosteroid-Antibiotic Interactions in Bacteria that Cause Corneal Infection.

Journal: Translational vision science & technology

Published: May 15, 2023

Synthetic Strategies for Improving Solubility: Optimization of Novel Pyrazolo[1,5-a]pyrimidine CFTR Activator That Ameliorates Dry Eye Disease.

Synthetic Strategies for Improving Solubility: Optimization of Novel Pyrazolo[1,5-a]pyrimidine CFTR Activator That Ameliorates Dry Eye Disease.

Journal: Journal of medicinal chemistry

Published: December 27, 2022

Activation of ADRB2/PKA Signaling Pathway Facilitates Lipid Synthesis in Meibocytes, and Beta-Blocker Glaucoma Drug Impedes PKA-Induced Lipid Synthesis by Inhibiting ADRB2.

Activation of ADRB2/PKA Signaling Pathway Facilitates Lipid Synthesis in Meibocytes, and Beta-Blocker Glaucoma Drug Impedes PKA-Induced Lipid Synthesis by Inhibiting ADRB2.

Journal: International journal of molecular sciences

Published: July 01, 2022

Novel CFTR Activator Cact-3 Ameliorates Ocular Surface Dysfunctions in Scopolamine-Induced Dry Eye Mice.

Novel CFTR Activator Cact-3 Ameliorates Ocular Surface Dysfunctions in Scopolamine-Induced Dry Eye Mice.

Journal: International journal of molecular sciences

Published: March 24, 2022

Comparison of Treatment Modalities for Dry Eye in Primary Sjögren's Syndrome.

Comparison of Treatment Modalities for Dry Eye in Primary Sjögren's Syndrome.

Journal: Journal of clinical medicine

Published: December 23, 2021

Effects of meibomian gland dysfunction and aqueous deficiency on friction-related disease.

Effects of meibomian gland dysfunction and aqueous deficiency on friction-related disease.

Journal: The ocular surface

Published: October 18, 2021

The Dopaminergic Neuronal System Regulates the Inflammatory Status of Mouse Lacrimal Glands in Dry Eye Disease.

The Dopaminergic Neuronal System Regulates the Inflammatory Status of Mouse Lacrimal Glands in Dry Eye Disease.

Journal: Investigative ophthalmology & visual science

Published: April 12, 2021

Showing 1-12 of 31

Last Updated: 09/26/2026